Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation

Journal of Clinical Epidemiology

Volumn 49, Issue 4, 1996, Pages 395-400

  Horwitz, Ralph I ^a   Singer, Burton H ^b   Makuch, Robert W ^a   Viscoli, Catherine M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Clinical decision making; Myocardial infarction; Randomized clinical trials; blockers

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; PROPRANOLOL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DRUG SCREENING; FEMALE; HEART INFARCTION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METHODOLOGY; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; UNITED STATES;

EID: 0029920389     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00058-5     Document Type: Article

References (16)

1. Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science 1977; 198: 679-684.
2. Rabeneck L, Viscoli CM, Horwitz RI. Problems in the conduct and analysis of randomized clinical trials: Are we getting the right answers to the wrong questions. Arch Intern Med 1992; 152: 507-512.
3. Peto R. Statistical aspects of cancer trials. In: Treatment of Cancer (Halnan KE, ed.). Chapman and Hall, London, 1982, pp. 867-871.
4. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41: 361-372.
5. Fleiss JL. Multicentre clinical trials: Bradford Hill's contributions and some subsequent developments. Statist Med 1982; 1: 353-359.
6. Simon R. Patient subsets and variation in therapeutic efficacy. Br J Clin Pharmacol 1982; 14: 473-482.
7. Azzalini A, Cox DR. Two new tests associated with analysis of variance. J R Statist Soc Ser B 1984; 46: 335-343.
8. Gunnar RM, Loeb HS. Editorial: An alternative interpretation of the results of the Coronary Artery Surgery Study. Circulation 1985; 71(2): 193-194.
9. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247(12): 1707-1714.
10. Freiman J, Chalmers TC, Smith H, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med 1978; 299: 690-694.
11. Horwitz RI. Complexity and contradiction in clinical trial research. Am J Med 1987; 82: 498-510.
12. Furberg CD, Byington RP. What do subgroup analyses reveal about differential response to beta-blocker therapy? Circulation 1983; 67(1): 198-1101.
13. Jafri SM, Tilley BC, Peters P, Schultz LR, Goldstein S. Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol 1990; 65: 271-276.
14. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart. Circulation 1986; 73(3): 503-510.
15. Loeb HS, Pifarre R, Sullivan H, Palac R, Croke RP, Gunnar RM. Improved survival after surgical therapy for chronic angina pectoris. Cardiovasc Surg 1979; 60(2): 122-28.
16. Detre KM, Hultgren HN, Murphy ML, Peduzzi P, Sako Y, Takaro T. Discussion: Executive Committee of the VA Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Cardiovasc Surg 1979; 60(2): 128-30.